Journal Title
Stem Cell Research & Therapy

STEM CELL RES THER

ISSN / eISSN
1757-6512 / 1757-6512
Aims and Scope
Stem Cell Research & Therapy is the major forum for translational research into stem cell therapies. An international peer-reviewed journal, it publishes high-quality open access research articles with a special emphasis on basic, translational and clinical research into stem cell therapeutics and regenerative therapies, including animal models and clinical trials. The journal also provides reviews, viewpoints, commentaries and reports.
Subject Area

CELL & TISSUE ENGINEERING

CELL BIOLOGY

MEDICINE, RESEARCH & EXPERIMENTAL

CiteScore
11.80 View Trend
CiteScore Ranking
Category Quartile Rank
Biochemistry, Genetics and Molecular Biology - Biochemistry, Genetics and Molecular Biology (miscellaneous) Q1 #3/79
Biochemistry, Genetics and Molecular Biology - Medicine (miscellaneous) Q1 #21/309
Biochemistry, Genetics and Molecular Biology - Molecular Medicine Q1 #22/171
Biochemistry, Genetics and Molecular Biology - Cell Biology Q1 #44/274
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
CELL & TISSUE ENGINEERING - SCIE Q1
CELL BIOLOGY - SCIE Q1
MEDICINE, RESEARCH & EXPERIMENTAL - SCIE Q1
H-index
56
Country/Area of Publication
ENGLAND
Publisher
BioMed Central
Year Publication Started
2010
Annual Article Volume
494
Open Access
YES
Contact
CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
Very frustrating magazine! After submitting the manuscript, it was quickly reviewed and requested to supplement experiments. After completing the experiments, it took about a month to be accepted and paid the publication fee. Then the frustrating part began. The editor kept asking questions. Because we had sequencing data, they first requested it to be publicly available in a database, as we wanted to continue exploring the data. We uploaded it to GEO and selected to make it public after two years, but the editor disagreed and demanded immediate public access. We had no choice but to make it public. Afterwards, they raised issues with our Western blot (WB) images. Our WB was used to validate the overexpression and knockdown effects of a gene in different human samples, and then exposed on a single membrane. The editor claimed that the intensity difference between the control bands of the two groups was too large and did not accept the results. Human samples naturally have different expressions, and we were only verifying the performance of the vector. We also provided the raw data and detailed explanations, but it was still rejected because of this reason. Dealing with these issues took almost half a year after receiving the response, which was particularly frustrating. It is very unprofessional to accept and charge a publication fee before resolving the problems.
2022-07-20
I am in the same situation as you. After receiving it, the ethical review took one and a half months. Four ethical review reports were issued back and forth. It was a constant struggle. Then the data was reviewed, and it was also a struggle in various ways. In the end, it was rejected. You can download the MESS app to have a look. There are a lot of such problems in it. I do not recommend submitting.
2022-11-15

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started